Life Science Leader Chief Editor Blog Header image Life Science Leader Chief Editor Blog Header image

From Utrecht To Amsterdam — Day 3 Of The Netherlands’ Biopharma Press Tour — Part 2
From Utrecht To Amsterdam — Day 3 Of The Netherlands’ Biopharma Press Tour — Part 2 The Netherlands’ biopharma press tour concludes in Amsterdam with presentations (e.g., AIMM Therapeutics) and guided tours of the O2 building and the National Screening Laboratory (NSS) for Sanquin.  Continue Reading...
From Utrecht To Amsterdam — Day 3 Of The Netherlands’ Biopharma Press Tour — Part 1
From Utrecht To Amsterdam — Day 3 Of The Netherlands’ Biopharma Press Tour — Part 1 Day 3 of the Netherlands’ biopharma press tour begins with presentations at the Utrecht Science Park (USP).  Continue Reading...
The Board Meeting West — More Than Just A Pre-JPM Appetizer?
The Board Meeting West — More Than Just A Pre-JPM Appetizer? Rob Wright provides insight into The Board Meeting West, a life sciences industry event for high-level biopharmaceutical executives serving on corporate boards, or hoping to do so in the near future.  Continue Reading...
There Is Value To Being At The Center Of The JPM Universe
There Is Value To Being At The Center Of The JPM Universe Rob Wright provides a bit of his perspective on the 37th Annual J.P. Morgan Healthcare Conference.  Continue Reading...
From Radboud UMC To Pivot Park — Day 2 Of The Netherlands’ Biopharma Press Tour
From Radboud UMC To Pivot Park — Day 2 Of The Netherlands’ Biopharma Press Tour Rob Wright shares experiences from day two of recent press tour of the Netherlands’ biopharmaceutical industry.  Continue Reading...
CNS Summit 2018 Does Not Meet Expectations — It Exceeded Them
CNS Summit 2018 Does Not Meet Expectations — It Exceeded Them Rob Wright shares what makes the CNS Summit the best conference he has ever attended.  Continue Reading...
The Netherlands — More Than Just The New Home Of The EMA
The Netherlands — More Than Just The New Home Of The EMA What sets the Netherlands biopharma sector apart from the rest of the world? That’s what Chief Editor Rob Wright hoped to find out as he began his press tour of the country’s biopharma industry.  Continue Reading...
Can China Be Trusted?
Can China Be Trusted? Rob Wright discusses China’s history of intellectual property (IP) theft, and wonders if the government-sponsored 10-year initiative, Made in China 2025 (MIC 2025), could exacerbate the problem.  Continue Reading...
The Future Of Biopharma — Netherlands Style
The Future Of Biopharma — Netherlands Style Rob Wright shares what he looks forward to learning about during an upcoming press tour of the Netherlands, beyond the fact that the European Medicines Agency (EMA) will be relocating there in 2019.  Continue Reading...
What Mylan Could Learn About Accountability
What Mylan Could Learn About Accountability Mylan’s inability to adequately supply its EpiPen during the 2018 back-to-school time is the latest example of corporate leadership lacking accountability.  Continue Reading...